11 | ThrombinFDA Link
08/2020
-
04/2006 |
10 | OrexinsIBA
01/2018
-
02/2004 |
9 | Therapeutic UsesIBA
12/2023
-
09/2011 |
8 | Collagenases (Collagenase)FDA Link
05/2024
-
07/2007 |
8 | tamibaroteneIBA
09/2023
-
07/2009 |
8 | Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
09/2023
-
01/2011 |
6 | Neuroprotective AgentsIBA
05/2024
-
01/2003 |
6 | Proteins (Proteins, Gene)FDA Link
01/2021
-
02/2009 |
5 | RetinoidsIBA
01/2023
-
01/2011 |
5 | LigandsIBA
01/2022
-
11/2002 |
5 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017
-
12/2003 |
5 | Glutamic Acid (Glutamate)FDA Link
02/2007
-
07/2004 |
4 | Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2023
-
10/2008 |
4 | Glycoproteins (Glycoprotein)IBA
01/2021
-
10/2009 |
4 | CytokinesIBA
08/2020
-
02/2009 |
4 | Retinaldehyde (Retinal)IBA
03/2006
-
01/2003 |
3 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2024
-
12/2021 |
3 | CholesterolIBA
01/2023
-
01/2021 |
3 | NicotineFDA Link
09/2021
-
09/2011 |
3 | Cysteine (L-Cysteine)FDA Link
01/2021
-
10/2005 |
3 | Adenosine Triphosphatases (ATPase)IBA
09/2019
-
01/2016 |
3 | NeuropeptidesIBA
01/2017
-
01/2010 |
3 | Messenger RNA (mRNA)IBA
01/2016
-
02/2009 |
3 | Mitogen-Activated Protein KinasesIBA
10/2015
-
07/2007 |
3 | Nitric Oxide Synthase (NO Synthase)IBA
12/2014
-
01/2004 |
3 | Oxygen (Dioxygen)IBA
01/2009
-
10/2004 |
3 | Dopamine (Intropin)FDA LinkGeneric
03/2008
-
10/2005 |
3 | Donepezil (Aricept)FDA LinkGeneric
08/2007
-
08/2003 |
3 | N-Methylaspartate (NMDA)IBA
03/2006
-
01/2003 |
3 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2004
-
11/2002 |
3 | Glucose (Dextrose)FDA LinkGeneric
11/2004
-
09/2004 |
2 | Amodiaquine (Camoquin)FDA Link
01/2022
-
01/2019 |
2 | GlucocorticoidsIBA
12/2020
-
01/2010 |
2 | EnzymesIBA
08/2020
-
11/2004 |
2 | Leukotriene B4IBA
08/2020
-
01/2017 |
2 | Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
10/2015
-
01/2004 |
2 | Dopamine Agonists (Dopamine Agonist)IBA
01/2012
-
12/2010 |
2 | ropinirole (Requip)FDA LinkGeneric
01/2012
-
12/2010 |
2 | Glycyrrhizic Acid (Glycyrrhizin)IBA
10/2011
-
01/2010 |
2 | Blood Coagulation Factors (Coagulation Factor)IBA
08/2010
-
01/2009 |
2 | Serine Proteases (Serine Protease)IBA
08/2010
-
04/2006 |
2 | LipopolysaccharidesIBA
01/2010
-
07/2009 |
2 | Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2007
-
09/2006 |
2 | Glutathione (Reduced Glutathione)IBA
02/2007
-
10/2005 |
2 | quinone (benzoquinone)IBA
10/2005
-
03/2005 |
1 | menatetrenoneIBA
05/2024 |
1 | oryeongsanIBA
02/2024 |
1 | allicinIBA
12/2023 |
1 | 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
09/2023 |
1 | (2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
09/2023 |
1 | OligosaccharidesIBA
01/2023 |
1 | CyclodextrinsIBA
01/2023 |
1 | AlbuminsIBA
11/2022 |
1 | Dextrans (Dextran)FDA Link
11/2022 |
1 | OvalbuminIBA
11/2022 |
1 | Protons (Proton)IBA
11/2022 |
1 | SodiumIBA
01/2022 |
1 | CC ChemokinesIBA
01/2022 |